Global Human Genetically Engineered Vaccine Supply, Demand and Key Producers, 2023-2029
The global Human Genetically Engineered Vaccine market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Human Genetically Engineered Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Genetically Engineered Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Genetically Engineered Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Genetically Engineered Vaccine total production and demand, 2018-2029, (K Units)
Global Human Genetically Engineered Vaccine total production value, 2018-2029, (USD Million)
Global Human Genetically Engineered Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Genetically Engineered Vaccine domestic production, consumption, key domestic manufacturers and share
Global Human Genetically Engineered Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Genetically Engineered Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Chengdu Kanghua Biological Products Co., Ltd., South China Vaccine Corporation Limited and Beijing Health Guard Biotechnology Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Genetically Engineered Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Genetically Engineered Vaccine Market, By Region:
1. How big is the global Human Genetically Engineered Vaccine market?
2. What is the demand of the global Human Genetically Engineered Vaccine market?
3. What is the year over year growth of the global Human Genetically Engineered Vaccine market?
4. What is the production and production value of the global Human Genetically Engineered Vaccine market?
5. Who are the key producers in the global Human Genetically Engineered Vaccine market?
6. What are the growth factors driving the market demand?
This report studies the global Human Genetically Engineered Vaccine production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Genetically Engineered Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Genetically Engineered Vaccine that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Genetically Engineered Vaccine total production and demand, 2018-2029, (K Units)
Global Human Genetically Engineered Vaccine total production value, 2018-2029, (USD Million)
Global Human Genetically Engineered Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Human Genetically Engineered Vaccine domestic production, consumption, key domestic manufacturers and share
Global Human Genetically Engineered Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Human Genetically Engineered Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Human Genetically Engineered Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck, GSK, Beijing Wantai Biological Pharmacy Enterprise CO.,LTD., Walvax Biotechnology Co., Ltd., Bharat Biotech, Chengdu Kanghua Biological Products Co., Ltd., South China Vaccine Corporation Limited and Beijing Health Guard Biotechnology Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Human Genetically Engineered Vaccine market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Human Genetically Engineered Vaccine Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Genetic Recombinant Vaccine
- Recombinant Subunit Vaccines
- Genetic Vaccine
- Hepatitis E
- Human Papillomavirus (HPV)
- Rotavirus
- Others
- Pfizer
- Merck
- GSK
- Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
- Walvax Biotechnology Co., Ltd.
- Bharat Biotech
- Chengdu Kanghua Biological Products Co., Ltd.
- South China Vaccine Corporation Limited
- Beijing Health Guard Biotechnology Inc.
- CSL Limited
- Emergent BioSolutions
- Sanofi Pasteur
- Serum Institute
1. How big is the global Human Genetically Engineered Vaccine market?
2. What is the demand of the global Human Genetically Engineered Vaccine market?
3. What is the year over year growth of the global Human Genetically Engineered Vaccine market?
4. What is the production and production value of the global Human Genetically Engineered Vaccine market?
5. Who are the key producers in the global Human Genetically Engineered Vaccine market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Human Genetically Engineered Vaccine Introduction
1.2 World Human Genetically Engineered Vaccine Supply & Forecast
1.2.1 World Human Genetically Engineered Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Human Genetically Engineered Vaccine Production (2018-2029)
1.2.3 World Human Genetically Engineered Vaccine Pricing Trends (2018-2029)
1.3 World Human Genetically Engineered Vaccine Production by Region (Based on Production Site)
1.3.1 World Human Genetically Engineered Vaccine Production Value by Region (2018-2029)
1.3.2 World Human Genetically Engineered Vaccine Production by Region (2018-2029)
1.3.3 World Human Genetically Engineered Vaccine Average Price by Region (2018-2029)
1.3.4 North America Human Genetically Engineered Vaccine Production (2018-2029)
1.3.5 Europe Human Genetically Engineered Vaccine Production (2018-2029)
1.3.6 China Human Genetically Engineered Vaccine Production (2018-2029)
1.3.7 Japan Human Genetically Engineered Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Genetically Engineered Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Genetically Engineered Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Genetically Engineered Vaccine Demand (2018-2029)
2.2 World Human Genetically Engineered Vaccine Consumption by Region
2.2.1 World Human Genetically Engineered Vaccine Consumption by Region (2018-2023)
2.2.2 World Human Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Human Genetically Engineered Vaccine Consumption (2018-2029)
2.4 China Human Genetically Engineered Vaccine Consumption (2018-2029)
2.5 Europe Human Genetically Engineered Vaccine Consumption (2018-2029)
2.6 Japan Human Genetically Engineered Vaccine Consumption (2018-2029)
2.7 South Korea Human Genetically Engineered Vaccine Consumption (2018-2029)
2.8 ASEAN Human Genetically Engineered Vaccine Consumption (2018-2029)
2.9 India Human Genetically Engineered Vaccine Consumption (2018-2029)
3 WORLD HUMAN GENETICALLY ENGINEERED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Human Genetically Engineered Vaccine Production by Manufacturer (2018-2023)
3.3 World Human Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023)
3.4 Human Genetically Engineered Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Genetically Engineered Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Genetically Engineered Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Genetically Engineered Vaccine in 2022
3.6 Human Genetically Engineered Vaccine Market: Overall Company Footprint Analysis
3.6.1 Human Genetically Engineered Vaccine Market: Region Footprint
3.6.2 Human Genetically Engineered Vaccine Market: Company Product Type Footprint
3.6.3 Human Genetically Engineered Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Genetically Engineered Vaccine Production Value Comparison
4.1.1 United States VS China: Human Genetically Engineered Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Genetically Engineered Vaccine Production Comparison
4.2.1 United States VS China: Human Genetically Engineered Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Genetically Engineered Vaccine Consumption Comparison
4.3.1 United States VS China: Human Genetically Engineered Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
4.5 China Based Human Genetically Engineered Vaccine Manufacturers and Market Share
4.5.1 China Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
4.6 Rest of World Based Human Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Genetically Engineered Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genetic Recombinant Vaccine
5.2.2 Recombinant Subunit Vaccines
5.2.3 Genetic Vaccine
5.3 Market Segment by Type
5.3.1 World Human Genetically Engineered Vaccine Production by Type (2018-2029)
5.3.2 World Human Genetically Engineered Vaccine Production Value by Type (2018-2029)
5.3.3 World Human Genetically Engineered Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Genetically Engineered Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hepatitis E
6.2.2 Human Papillomavirus (HPV)
6.2.3 Rotavirus
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Human Genetically Engineered Vaccine Production by Application (2018-2029)
6.3.2 World Human Genetically Engineered Vaccine Production Value by Application (2018-2029)
6.3.3 World Human Genetically Engineered Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Human Genetically Engineered Vaccine Product and Services
7.1.4 Pfizer Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Human Genetically Engineered Vaccine Product and Services
7.2.4 Merck Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Human Genetically Engineered Vaccine Product and Services
7.3.4 GSK Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Details
7.5.2 Walvax Biotechnology Co., Ltd. Major Business
7.5.3 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product and Services
7.5.4 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Walvax Biotechnology Co., Ltd. Recent Developments/Updates
7.5.6 Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Human Genetically Engineered Vaccine Product and Services
7.6.4 Bharat Biotech Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Chengdu Kanghua Biological Products Co., Ltd.
7.7.1 Chengdu Kanghua Biological Products Co., Ltd. Details
7.7.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
7.7.3 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product and Services
7.7.4 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
7.7.6 Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.8 South China Vaccine Corporation Limited
7.8.1 South China Vaccine Corporation Limited Details
7.8.2 South China Vaccine Corporation Limited Major Business
7.8.3 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product and Services
7.8.4 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 South China Vaccine Corporation Limited Recent Developments/Updates
7.8.6 South China Vaccine Corporation Limited Competitive Strengths & Weaknesses
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Details
7.9.2 Beijing Health Guard Biotechnology Inc. Major Business
7.9.3 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product and Services
7.9.4 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
7.9.6 Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
7.10 CSL Limited
7.10.1 CSL Limited Details
7.10.2 CSL Limited Major Business
7.10.3 CSL Limited Human Genetically Engineered Vaccine Product and Services
7.10.4 CSL Limited Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CSL Limited Recent Developments/Updates
7.10.6 CSL Limited Competitive Strengths & Weaknesses
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Details
7.11.2 Emergent BioSolutions Major Business
7.11.3 Emergent BioSolutions Human Genetically Engineered Vaccine Product and Services
7.11.4 Emergent BioSolutions Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Emergent BioSolutions Recent Developments/Updates
7.11.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.12 Sanofi Pasteur
7.12.1 Sanofi Pasteur Details
7.12.2 Sanofi Pasteur Major Business
7.12.3 Sanofi Pasteur Human Genetically Engineered Vaccine Product and Services
7.12.4 Sanofi Pasteur Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sanofi Pasteur Recent Developments/Updates
7.12.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.13 Serum Institute
7.13.1 Serum Institute Details
7.13.2 Serum Institute Major Business
7.13.3 Serum Institute Human Genetically Engineered Vaccine Product and Services
7.13.4 Serum Institute Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Serum Institute Recent Developments/Updates
7.13.6 Serum Institute Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Genetically Engineered Vaccine Industry Chain
8.2 Human Genetically Engineered Vaccine Upstream Analysis
8.2.1 Human Genetically Engineered Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Human Genetically Engineered Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Genetically Engineered Vaccine Production Mode
8.6 Human Genetically Engineered Vaccine Procurement Model
8.7 Human Genetically Engineered Vaccine Industry Sales Model and Sales Channels
8.7.1 Human Genetically Engineered Vaccine Sales Model
8.7.2 Human Genetically Engineered Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Human Genetically Engineered Vaccine Introduction
1.2 World Human Genetically Engineered Vaccine Supply & Forecast
1.2.1 World Human Genetically Engineered Vaccine Production Value (2018 & 2022 & 2029)
1.2.2 World Human Genetically Engineered Vaccine Production (2018-2029)
1.2.3 World Human Genetically Engineered Vaccine Pricing Trends (2018-2029)
1.3 World Human Genetically Engineered Vaccine Production by Region (Based on Production Site)
1.3.1 World Human Genetically Engineered Vaccine Production Value by Region (2018-2029)
1.3.2 World Human Genetically Engineered Vaccine Production by Region (2018-2029)
1.3.3 World Human Genetically Engineered Vaccine Average Price by Region (2018-2029)
1.3.4 North America Human Genetically Engineered Vaccine Production (2018-2029)
1.3.5 Europe Human Genetically Engineered Vaccine Production (2018-2029)
1.3.6 China Human Genetically Engineered Vaccine Production (2018-2029)
1.3.7 Japan Human Genetically Engineered Vaccine Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Human Genetically Engineered Vaccine Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Human Genetically Engineered Vaccine Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Human Genetically Engineered Vaccine Demand (2018-2029)
2.2 World Human Genetically Engineered Vaccine Consumption by Region
2.2.1 World Human Genetically Engineered Vaccine Consumption by Region (2018-2023)
2.2.2 World Human Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029)
2.3 United States Human Genetically Engineered Vaccine Consumption (2018-2029)
2.4 China Human Genetically Engineered Vaccine Consumption (2018-2029)
2.5 Europe Human Genetically Engineered Vaccine Consumption (2018-2029)
2.6 Japan Human Genetically Engineered Vaccine Consumption (2018-2029)
2.7 South Korea Human Genetically Engineered Vaccine Consumption (2018-2029)
2.8 ASEAN Human Genetically Engineered Vaccine Consumption (2018-2029)
2.9 India Human Genetically Engineered Vaccine Consumption (2018-2029)
3 WORLD HUMAN GENETICALLY ENGINEERED VACCINE MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Human Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023)
3.2 World Human Genetically Engineered Vaccine Production by Manufacturer (2018-2023)
3.3 World Human Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023)
3.4 Human Genetically Engineered Vaccine Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Human Genetically Engineered Vaccine Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Human Genetically Engineered Vaccine in 2022
3.5.3 Global Concentration Ratios (CR8) for Human Genetically Engineered Vaccine in 2022
3.6 Human Genetically Engineered Vaccine Market: Overall Company Footprint Analysis
3.6.1 Human Genetically Engineered Vaccine Market: Region Footprint
3.6.2 Human Genetically Engineered Vaccine Market: Company Product Type Footprint
3.6.3 Human Genetically Engineered Vaccine Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Human Genetically Engineered Vaccine Production Value Comparison
4.1.1 United States VS China: Human Genetically Engineered Vaccine Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Human Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Human Genetically Engineered Vaccine Production Comparison
4.2.1 United States VS China: Human Genetically Engineered Vaccine Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Human Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Human Genetically Engineered Vaccine Consumption Comparison
4.3.1 United States VS China: Human Genetically Engineered Vaccine Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Human Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Human Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.4.3 United States Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
4.5 China Based Human Genetically Engineered Vaccine Manufacturers and Market Share
4.5.1 China Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.5.3 China Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
4.6 Rest of World Based Human Genetically Engineered Vaccine Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Human Genetically Engineered Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Genetic Recombinant Vaccine
5.2.2 Recombinant Subunit Vaccines
5.2.3 Genetic Vaccine
5.3 Market Segment by Type
5.3.1 World Human Genetically Engineered Vaccine Production by Type (2018-2029)
5.3.2 World Human Genetically Engineered Vaccine Production Value by Type (2018-2029)
5.3.3 World Human Genetically Engineered Vaccine Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Human Genetically Engineered Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hepatitis E
6.2.2 Human Papillomavirus (HPV)
6.2.3 Rotavirus
6.2.4 Others
6.3 Market Segment by Application
6.3.1 World Human Genetically Engineered Vaccine Production by Application (2018-2029)
6.3.2 World Human Genetically Engineered Vaccine Production Value by Application (2018-2029)
6.3.3 World Human Genetically Engineered Vaccine Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Human Genetically Engineered Vaccine Product and Services
7.1.4 Pfizer Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Merck
7.2.1 Merck Details
7.2.2 Merck Major Business
7.2.3 Merck Human Genetically Engineered Vaccine Product and Services
7.2.4 Merck Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Merck Recent Developments/Updates
7.2.6 Merck Competitive Strengths & Weaknesses
7.3 GSK
7.3.1 GSK Details
7.3.2 GSK Major Business
7.3.3 GSK Human Genetically Engineered Vaccine Product and Services
7.3.4 GSK Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GSK Recent Developments/Updates
7.3.6 GSK Competitive Strengths & Weaknesses
7.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD.
7.4.1 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Details
7.4.2 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
7.4.3 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product and Services
7.4.4 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
7.4.6 Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
7.5 Walvax Biotechnology Co., Ltd.
7.5.1 Walvax Biotechnology Co., Ltd. Details
7.5.2 Walvax Biotechnology Co., Ltd. Major Business
7.5.3 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product and Services
7.5.4 Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Walvax Biotechnology Co., Ltd. Recent Developments/Updates
7.5.6 Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
7.6 Bharat Biotech
7.6.1 Bharat Biotech Details
7.6.2 Bharat Biotech Major Business
7.6.3 Bharat Biotech Human Genetically Engineered Vaccine Product and Services
7.6.4 Bharat Biotech Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Bharat Biotech Recent Developments/Updates
7.6.6 Bharat Biotech Competitive Strengths & Weaknesses
7.7 Chengdu Kanghua Biological Products Co., Ltd.
7.7.1 Chengdu Kanghua Biological Products Co., Ltd. Details
7.7.2 Chengdu Kanghua Biological Products Co., Ltd. Major Business
7.7.3 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product and Services
7.7.4 Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
7.7.6 Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
7.8 South China Vaccine Corporation Limited
7.8.1 South China Vaccine Corporation Limited Details
7.8.2 South China Vaccine Corporation Limited Major Business
7.8.3 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product and Services
7.8.4 South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 South China Vaccine Corporation Limited Recent Developments/Updates
7.8.6 South China Vaccine Corporation Limited Competitive Strengths & Weaknesses
7.9 Beijing Health Guard Biotechnology Inc.
7.9.1 Beijing Health Guard Biotechnology Inc. Details
7.9.2 Beijing Health Guard Biotechnology Inc. Major Business
7.9.3 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product and Services
7.9.4 Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
7.9.6 Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
7.10 CSL Limited
7.10.1 CSL Limited Details
7.10.2 CSL Limited Major Business
7.10.3 CSL Limited Human Genetically Engineered Vaccine Product and Services
7.10.4 CSL Limited Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 CSL Limited Recent Developments/Updates
7.10.6 CSL Limited Competitive Strengths & Weaknesses
7.11 Emergent BioSolutions
7.11.1 Emergent BioSolutions Details
7.11.2 Emergent BioSolutions Major Business
7.11.3 Emergent BioSolutions Human Genetically Engineered Vaccine Product and Services
7.11.4 Emergent BioSolutions Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 Emergent BioSolutions Recent Developments/Updates
7.11.6 Emergent BioSolutions Competitive Strengths & Weaknesses
7.12 Sanofi Pasteur
7.12.1 Sanofi Pasteur Details
7.12.2 Sanofi Pasteur Major Business
7.12.3 Sanofi Pasteur Human Genetically Engineered Vaccine Product and Services
7.12.4 Sanofi Pasteur Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Sanofi Pasteur Recent Developments/Updates
7.12.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.13 Serum Institute
7.13.1 Serum Institute Details
7.13.2 Serum Institute Major Business
7.13.3 Serum Institute Human Genetically Engineered Vaccine Product and Services
7.13.4 Serum Institute Human Genetically Engineered Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Serum Institute Recent Developments/Updates
7.13.6 Serum Institute Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Human Genetically Engineered Vaccine Industry Chain
8.2 Human Genetically Engineered Vaccine Upstream Analysis
8.2.1 Human Genetically Engineered Vaccine Core Raw Materials
8.2.2 Main Manufacturers of Human Genetically Engineered Vaccine Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Human Genetically Engineered Vaccine Production Mode
8.6 Human Genetically Engineered Vaccine Procurement Model
8.7 Human Genetically Engineered Vaccine Industry Sales Model and Sales Channels
8.7.1 Human Genetically Engineered Vaccine Sales Model
8.7.2 Human Genetically Engineered Vaccine Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Human Genetically Engineered Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Genetically Engineered Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Genetically Engineered Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Human Genetically Engineered Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Human Genetically Engineered Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Human Genetically Engineered Vaccine Production Market Share by Region (2018-2023)
Table 9. World Human Genetically Engineered Vaccine Production Market Share by Region (2024-2029)
Table 10. World Human Genetically Engineered Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Genetically Engineered Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Genetically Engineered Vaccine Major Market Trends
Table 13. World Human Genetically Engineered Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Genetically Engineered Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Genetically Engineered Vaccine Producers in 2022
Table 18. World Human Genetically Engineered Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Genetically Engineered Vaccine Producers in 2022
Table 20. World Human Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Genetically Engineered Vaccine Company Evaluation Quadrant
Table 22. World Human Genetically Engineered Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Genetically Engineered Vaccine Production Site of Key Manufacturer
Table 24. Human Genetically Engineered Vaccine Market: Company Product Type Footprint
Table 25. Human Genetically Engineered Vaccine Market: Company Product Application Footprint
Table 26. Human Genetically Engineered Vaccine Competitive Factors
Table 27. Human Genetically Engineered Vaccine New Entrant and Capacity Expansion Plans
Table 28. Human Genetically Engineered Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Human Genetically Engineered Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Genetically Engineered Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Genetically Engineered Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 37. China Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 47. World Human Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Genetically Engineered Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Human Genetically Engineered Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Human Genetically Engineered Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Genetically Engineered Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Genetically Engineered Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Genetically Engineered Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Genetically Engineered Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Human Genetically Engineered Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Human Genetically Engineered Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Genetically Engineered Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Genetically Engineered Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Genetically Engineered Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Human Genetically Engineered Vaccine Product and Services
Table 64. Pfizer Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Human Genetically Engineered Vaccine Product and Services
Table 70. Merck Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Human Genetically Engineered Vaccine Product and Services
Table 76. GSK Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Co., Ltd. Major Business
Table 87. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product and Services
Table 88. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Human Genetically Engineered Vaccine Product and Services
Table 94. Bharat Biotech Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 99. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product and Services
Table 100. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 102. Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 103. South China Vaccine Corporation Limited Basic Information, Manufacturing Base and Competitors
Table 104. South China Vaccine Corporation Limited Major Business
Table 105. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product and Services
Table 106. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. South China Vaccine Corporation Limited Recent Developments/Updates
Table 108. South China Vaccine Corporation Limited Competitive Strengths & Weaknesses
Table 109. Beijing Health Guard Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Health Guard Biotechnology Inc. Major Business
Table 111. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product and Services
Table 112. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 114. Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
Table 115. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 116. CSL Limited Major Business
Table 117. CSL Limited Human Genetically Engineered Vaccine Product and Services
Table 118. CSL Limited Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CSL Limited Recent Developments/Updates
Table 120. CSL Limited Competitive Strengths & Weaknesses
Table 121. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 122. Emergent BioSolutions Major Business
Table 123. Emergent BioSolutions Human Genetically Engineered Vaccine Product and Services
Table 124. Emergent BioSolutions Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Emergent BioSolutions Recent Developments/Updates
Table 126. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 127. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 128. Sanofi Pasteur Major Business
Table 129. Sanofi Pasteur Human Genetically Engineered Vaccine Product and Services
Table 130. Sanofi Pasteur Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sanofi Pasteur Recent Developments/Updates
Table 132. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 133. Serum Institute Major Business
Table 134. Serum Institute Human Genetically Engineered Vaccine Product and Services
Table 135. Serum Institute Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Human Genetically Engineered Vaccine Upstream (Raw Materials)
Table 137. Human Genetically Engineered Vaccine Typical Customers
Table 138. Human Genetically Engineered Vaccine Typical Distributors
Table 1. World Human Genetically Engineered Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Human Genetically Engineered Vaccine Production Value by Region (2018-2023) & (USD Million)
Table 3. World Human Genetically Engineered Vaccine Production Value by Region (2024-2029) & (USD Million)
Table 4. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2018-2023)
Table 5. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2024-2029)
Table 6. World Human Genetically Engineered Vaccine Production by Region (2018-2023) & (K Units)
Table 7. World Human Genetically Engineered Vaccine Production by Region (2024-2029) & (K Units)
Table 8. World Human Genetically Engineered Vaccine Production Market Share by Region (2018-2023)
Table 9. World Human Genetically Engineered Vaccine Production Market Share by Region (2024-2029)
Table 10. World Human Genetically Engineered Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Human Genetically Engineered Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Human Genetically Engineered Vaccine Major Market Trends
Table 13. World Human Genetically Engineered Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Human Genetically Engineered Vaccine Consumption by Region (2018-2023) & (K Units)
Table 15. World Human Genetically Engineered Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Human Genetically Engineered Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Human Genetically Engineered Vaccine Producers in 2022
Table 18. World Human Genetically Engineered Vaccine Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Human Genetically Engineered Vaccine Producers in 2022
Table 20. World Human Genetically Engineered Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Human Genetically Engineered Vaccine Company Evaluation Quadrant
Table 22. World Human Genetically Engineered Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Human Genetically Engineered Vaccine Production Site of Key Manufacturer
Table 24. Human Genetically Engineered Vaccine Market: Company Product Type Footprint
Table 25. Human Genetically Engineered Vaccine Market: Company Product Application Footprint
Table 26. Human Genetically Engineered Vaccine Competitive Factors
Table 27. Human Genetically Engineered Vaccine New Entrant and Capacity Expansion Plans
Table 28. Human Genetically Engineered Vaccine Mergers & Acquisitions Activity
Table 29. United States VS China Human Genetically Engineered Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Human Genetically Engineered Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Human Genetically Engineered Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 37. China Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 42. Rest of World Based Human Genetically Engineered Vaccine Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Market Share (2018-2023)
Table 47. World Human Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Human Genetically Engineered Vaccine Production by Type (2018-2023) & (K Units)
Table 49. World Human Genetically Engineered Vaccine Production by Type (2024-2029) & (K Units)
Table 50. World Human Genetically Engineered Vaccine Production Value by Type (2018-2023) & (USD Million)
Table 51. World Human Genetically Engineered Vaccine Production Value by Type (2024-2029) & (USD Million)
Table 52. World Human Genetically Engineered Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Human Genetically Engineered Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Human Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Human Genetically Engineered Vaccine Production by Application (2018-2023) & (K Units)
Table 56. World Human Genetically Engineered Vaccine Production by Application (2024-2029) & (K Units)
Table 57. World Human Genetically Engineered Vaccine Production Value by Application (2018-2023) & (USD Million)
Table 58. World Human Genetically Engineered Vaccine Production Value by Application (2024-2029) & (USD Million)
Table 59. World Human Genetically Engineered Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Human Genetically Engineered Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Human Genetically Engineered Vaccine Product and Services
Table 64. Pfizer Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Merck Basic Information, Manufacturing Base and Competitors
Table 68. Merck Major Business
Table 69. Merck Human Genetically Engineered Vaccine Product and Services
Table 70. Merck Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Merck Recent Developments/Updates
Table 72. Merck Competitive Strengths & Weaknesses
Table 73. GSK Basic Information, Manufacturing Base and Competitors
Table 74. GSK Major Business
Table 75. GSK Human Genetically Engineered Vaccine Product and Services
Table 76. GSK Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GSK Recent Developments/Updates
Table 78. GSK Competitive Strengths & Weaknesses
Table 79. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Basic Information, Manufacturing Base and Competitors
Table 80. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Major Business
Table 81. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Product and Services
Table 82. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Recent Developments/Updates
Table 84. Beijing Wantai Biological Pharmacy Enterprise CO.,LTD. Competitive Strengths & Weaknesses
Table 85. Walvax Biotechnology Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 86. Walvax Biotechnology Co., Ltd. Major Business
Table 87. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Product and Services
Table 88. Walvax Biotechnology Co., Ltd. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Walvax Biotechnology Co., Ltd. Recent Developments/Updates
Table 90. Walvax Biotechnology Co., Ltd. Competitive Strengths & Weaknesses
Table 91. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 92. Bharat Biotech Major Business
Table 93. Bharat Biotech Human Genetically Engineered Vaccine Product and Services
Table 94. Bharat Biotech Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Bharat Biotech Recent Developments/Updates
Table 96. Bharat Biotech Competitive Strengths & Weaknesses
Table 97. Chengdu Kanghua Biological Products Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 98. Chengdu Kanghua Biological Products Co., Ltd. Major Business
Table 99. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Product and Services
Table 100. Chengdu Kanghua Biological Products Co., Ltd. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments/Updates
Table 102. Chengdu Kanghua Biological Products Co., Ltd. Competitive Strengths & Weaknesses
Table 103. South China Vaccine Corporation Limited Basic Information, Manufacturing Base and Competitors
Table 104. South China Vaccine Corporation Limited Major Business
Table 105. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Product and Services
Table 106. South China Vaccine Corporation Limited Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. South China Vaccine Corporation Limited Recent Developments/Updates
Table 108. South China Vaccine Corporation Limited Competitive Strengths & Weaknesses
Table 109. Beijing Health Guard Biotechnology Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Beijing Health Guard Biotechnology Inc. Major Business
Table 111. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Product and Services
Table 112. Beijing Health Guard Biotechnology Inc. Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Beijing Health Guard Biotechnology Inc. Recent Developments/Updates
Table 114. Beijing Health Guard Biotechnology Inc. Competitive Strengths & Weaknesses
Table 115. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 116. CSL Limited Major Business
Table 117. CSL Limited Human Genetically Engineered Vaccine Product and Services
Table 118. CSL Limited Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CSL Limited Recent Developments/Updates
Table 120. CSL Limited Competitive Strengths & Weaknesses
Table 121. Emergent BioSolutions Basic Information, Manufacturing Base and Competitors
Table 122. Emergent BioSolutions Major Business
Table 123. Emergent BioSolutions Human Genetically Engineered Vaccine Product and Services
Table 124. Emergent BioSolutions Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Emergent BioSolutions Recent Developments/Updates
Table 126. Emergent BioSolutions Competitive Strengths & Weaknesses
Table 127. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 128. Sanofi Pasteur Major Business
Table 129. Sanofi Pasteur Human Genetically Engineered Vaccine Product and Services
Table 130. Sanofi Pasteur Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Sanofi Pasteur Recent Developments/Updates
Table 132. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 133. Serum Institute Major Business
Table 134. Serum Institute Human Genetically Engineered Vaccine Product and Services
Table 135. Serum Institute Human Genetically Engineered Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 136. Global Key Players of Human Genetically Engineered Vaccine Upstream (Raw Materials)
Table 137. Human Genetically Engineered Vaccine Typical Customers
Table 138. Human Genetically Engineered Vaccine Typical Distributors
LIST OF FIGURES
Figure 1. Human Genetically Engineered Vaccine Picture
Figure 2. World Human Genetically Engineered Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Genetically Engineered Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 5. World Human Genetically Engineered Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Human Genetically Engineered Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 10. China Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 12. Human Genetically Engineered Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Human Genetically Engineered Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Genetically Engineered Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Genetically Engineered Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Genetically Engineered Vaccine Markets in 2022
Figure 26. United States VS China: Human Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 32. World Human Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Genetically Engineered Vaccine Production Value Market Share by Type in 2022
Figure 34. Genetic Recombinant Vaccine
Figure 35. Recombinant Subunit Vaccines
Figure 36. Genetic Vaccine
Figure 37. World Human Genetically Engineered Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Human Genetically Engineered Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Human Genetically Engineered Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Human Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Human Genetically Engineered Vaccine Production Value Market Share by Application in 2022
Figure 42. Hepatitis E
Figure 43. Human Papillomavirus (HPV)
Figure 44. Rotavirus
Figure 45. Others
Figure 46. World Human Genetically Engineered Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Human Genetically Engineered Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Human Genetically Engineered Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Human Genetically Engineered Vaccine Industry Chain
Figure 50. Human Genetically Engineered Vaccine Procurement Model
Figure 51. Human Genetically Engineered Vaccine Sales Model
Figure 52. Human Genetically Engineered Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Figure 1. Human Genetically Engineered Vaccine Picture
Figure 2. World Human Genetically Engineered Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Human Genetically Engineered Vaccine Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 5. World Human Genetically Engineered Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 6. World Human Genetically Engineered Vaccine Production Value Market Share by Region (2018-2029)
Figure 7. World Human Genetically Engineered Vaccine Production Market Share by Region (2018-2029)
Figure 8. North America Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 9. Europe Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 10. China Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 11. Japan Human Genetically Engineered Vaccine Production (2018-2029) & (K Units)
Figure 12. Human Genetically Engineered Vaccine Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 15. World Human Genetically Engineered Vaccine Consumption Market Share by Region (2018-2029)
Figure 16. United States Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 17. China Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 18. Europe Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 19. Japan Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 20. South Korea Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 22. India Human Genetically Engineered Vaccine Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Human Genetically Engineered Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Human Genetically Engineered Vaccine Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Human Genetically Engineered Vaccine Markets in 2022
Figure 26. United States VS China: Human Genetically Engineered Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Human Genetically Engineered Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Human Genetically Engineered Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 30. China Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Human Genetically Engineered Vaccine Production Market Share 2022
Figure 32. World Human Genetically Engineered Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Human Genetically Engineered Vaccine Production Value Market Share by Type in 2022
Figure 34. Genetic Recombinant Vaccine
Figure 35. Recombinant Subunit Vaccines
Figure 36. Genetic Vaccine
Figure 37. World Human Genetically Engineered Vaccine Production Market Share by Type (2018-2029)
Figure 38. World Human Genetically Engineered Vaccine Production Value Market Share by Type (2018-2029)
Figure 39. World Human Genetically Engineered Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 40. World Human Genetically Engineered Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Human Genetically Engineered Vaccine Production Value Market Share by Application in 2022
Figure 42. Hepatitis E
Figure 43. Human Papillomavirus (HPV)
Figure 44. Rotavirus
Figure 45. Others
Figure 46. World Human Genetically Engineered Vaccine Production Market Share by Application (2018-2029)
Figure 47. World Human Genetically Engineered Vaccine Production Value Market Share by Application (2018-2029)
Figure 48. World Human Genetically Engineered Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 49. Human Genetically Engineered Vaccine Industry Chain
Figure 50. Human Genetically Engineered Vaccine Procurement Model
Figure 51. Human Genetically Engineered Vaccine Sales Model
Figure 52. Human Genetically Engineered Vaccine Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
